A decade of HCV drugs
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Nature reviews. Drug discovery - 23(2024), 1 vom: 10. Jan., Seite 8 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mullard, Asher [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 08.01.2024 Date Revised 16.01.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1038/d41573-023-00200-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365483613 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365483613 | ||
| 003 | DE-627 | ||
| 005 | 20240117232053.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/d41573-023-00200-y |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1262.xml |
| 035 | |a (DE-627)NLM365483613 | ||
| 035 | |a (NLM)38057456 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mullard, Asher |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A decade of HCV drugs |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.01.2024 | ||
| 500 | |a Date Revised 16.01.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a News | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Nature reviews. Drug discovery |d 2002 |g 23(2024), 1 vom: 10. Jan., Seite 8 |w (DE-627)NLM119883511 |x 1474-1784 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2024 |g number:1 |g day:10 |g month:01 |g pages:8 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/d41573-023-00200-y |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2024 |e 1 |b 10 |c 01 |h 8 | ||